Evaluation of antiarthritic activity of Strychnos potatorum Linn seeds in Freund's adjuvant induced arthritic rat model

BMC Complementary and Alternative Medicine

Volumn 10, Issue , 2010, Pages

  Ekambaram, Sanmugapriya ^a   Perumal, Senthamil Selvan ^a   Subramanian, Venkataraman ^b  

^a ANNA UNIVERSITY   (India)

^b CL Baid Mehta Foundation for Pharmaceutical Education and Research   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; CREATININE; FREUND ADJUVANT; HEMOGLOBIN; PLANT EXTRACT; STRYCHNOS POTATORUM EXTRACT; UNCLASSIFIED DRUG; UREA; ANTIINFLAMMATORY AGENT; PLASMA PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHRITIS; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG INDUCED DISEASE; ERYTHROCYTE COUNT; ERYTHROCYTE SEDIMENTATION RATE; HEMOGLOBIN DETERMINATION; HINDLIMB; HISTOPATHOLOGY; INTERPHALANGEAL JOINT; LEUKOCYTE COUNT; LOGANIACEAE; MEDICINAL PLANT; NONHUMAN; PAW EDEMA; PLANT SEED; PROTEIN BLOOD LEVEL; RAT; STRYCHNOS POTATORUM; UREA BLOOD LEVEL; WEIGHT CHANGE; WEIGHT GAIN; ANIMAL; BLOOD; BLOOD EXAMINATION; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; EDEMA; LEG; METABOLISM; PATHOLOGY; PHYTOTHERAPY; STRYCHNOS; TRADITIONAL MEDICINE; WISTAR RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ARTHRITIS, EXPERIMENTAL; BLOOD PROTEINS; EDEMA; FREUND'S ADJUVANT; HEMATOLOGIC TESTS; LOWER EXTREMITY; MEDICINE, TRADITIONAL; PHYTOTHERAPY; PLANT EXTRACTS; RATS; RATS, WISTAR; SEEDS; STRYCHNOS; WEIGHT GAIN;

EID: 77957730858     PISSN: None     EISSN: 14726882     Source Type: Journal    
DOI: 10.1186/1472-6882-10-56     Document Type: Article

References (28)

1. Barbier A, Novarro JC, Brelliere Roncucci R. Biochemical and clinical changes in rats with the developing arthritis. Agents Actions 1984, 15:103-105.
2. Ward JR, Cloud RS. Comparative effect of antirheumatic drugs on adjuvant induced polyarthritis in rats. J Pharmacol Exp Ther 1966, 152:116-121.
3. Kirtikar KR, Basu BD. Indian medicinal plants. Allahabad 1933, 3:1647. Basu LM.
4. Kirtikar KR, Basu BD. Illustrated Indian Medicinal Plants. 2000, 7:2271. Sir Satguru's Publications, Mhaskar KS, Blatter E, Cains JF.
5. Asima C, Satyesh CP. The Treatise on Indian Medicinal Plants. 2001, 4:85-87. Publications and Information Directorate, CSIR.
6. Harkishan S, Kapoor VK, Phillipson JD, Bisset NG. Diaboline from Strychnos potatorum. Phytochem 1975, 14:587-588.
7. Harkishan S, Kapoor VK.: Investigation of Strychnos Spp.III Study of triterpenes and sterols of Strychnos potatorum seeds. Planta Med 1975, 28:392-396. 10.1055/s-0028-1097877, 1208692.
8. Adinolfi M, Corsaro MM, Lanzetta R, Parilli M, Folkard G, Grant W, Sutherland J. Composition of the coagulant polysaccharide fraction from Strychnos potatorum. Carbohydrate Res 1994, 263:103-110.
9. Mathuram LN, Samanna HC, Ramasamy VM, Natarajan R. Studies on the hypoglycemic effects of Strychnos potatorum and Acacia arabica on alloxan diabetes in rabbits. Cheiron 1981, 10(1):1-5.
10. Venkata Rao E, Ramana KS, Venkateswarao M. Revised structure and antihypercholesterolemic activity of a mannogalactan from Strychnos potatorum. Ind J Pharm Sci 1991, 53(2):53-57.
11. Biswas S, Murugesan T, Maiti K, Ghosh L, et al. Study on the diuretic activity of Strychnos potatorum Linn, seed extract in albino rats. Phytomed 2001, 8(6):469-471.
12. Swathi B, Murugesan T, Sanghamitra S, et al. Antidiarrhoeal activity of Strychnos potatorum seed extract in rats. Fitoterapia 2002, 73:43-47. 10.1016/S0367-326X(01)00368-9, 11864763.
13. Sanmuga priya E, Venkataraman S. Studies on hepatoprotective and antioxidant actions of Strychnos potatorum Linn seeds on CCl4 induced acute hepatic injury in experimental rats. J Ethnopharmacol 2006, 105:154-160. 10.1016/j.jep.2005.10.028, 16388923.
14. Sanmuga priya E, Venkataraman S. Antiulcerogenic potential of Strychnos potatorum Linn seeds in aspirin+pylorus ligation induced ulcers in experimental rats. Phytomed 2007, 14:360-365.
15. Yin W, Wang TS, Yin FZ, Cai BC. Analgesic and anti-inflammatory properties of brucine and brucine N- oxide extracted from seeds of Strychnos nuxvomica. J Ethnopharmacol 2003, 88:205-214. 10.1016/S0378-8741(03)00224-1, 12963144.
16. Newbould BB. Chemotherapy of arthritis induced in rats by injection of Mycobacterial adjuvant. Br J Pharmacol Chemother 1963, 21:127-137. 1703866, 14066137.
17. Reinhold JG. Standard Methods of Clinical Chemistry. 1953, 1:88. Academic Press, New York, Reiner M.
18. Ratnoff OD, Menzie C. A new method for the determination of fibrinogen in small samples of plasma. J lab Clin Med 1951, 37:316-320.
19. Henry RJ, Chiamori N, Jacob SL, Seaglore N. Determination of ceruloplasmin oxidase in serum. Proc Soc Exp Biol Med 1960, 104:620-624.
20. Yoshikawa T, Tanaka H, Kondo M. The increase in lipid peroxidation in rat adjuvant arthritis and its inhibition by Superoxide dismutase. Biochem. Med 1985, 33:320-326. 10.1016/0006-2944(85)90006-7, 4015632.
21. Mowat AG. Hematologic abnormalities in Rheumatoid arthritis. Sem. Arthr. Rheum 1971, 1(3):195-219.
22. Filho PY, Bracht A, Ishii-Iwato EL, Lousano SH, Bracht L, Kelmer-Bracht AM. The urea cycle in the liver of arthritic rats. Mol Cell Biochem 2003, 243:97-106. 10.1023/A:1021695625457, 12619894.
23. Cawthorne MA, Palmer ED, Green J. Adjuvant induced arthritis and drug metabolising enzymes. Biochem Pharmacol 1976, 25:2683-2688. 10.1016/0006-2952(76)90257-4, 1008892.
24. Kohn A, Barchet E. Correlation between albumin permeability and adenosine cyclic monophosphate levels in incubated rat mesentry tissue. CR Seances Soc Biol Ses Fil 1976, 170:270-330.
25. Whicher JT, Dieppe PA. Acute phase proteins. Clin Immunol Allergy 1985, 5:425-446.
26. Denko CW. Protective role of ceruloplasmin in inflammation. Agents Actions 1979, 914:333-336.
27. Fisher CL, Gill CW. Acute phase protein. Serum protein abnormalities: Diagnostic and Clinical aspects 1975, 331-351. Little Brown & Co., Boston, Ritzman SE, Daniels JC.
28. Harris ED. Rheumatoid arthritis. Pathophysiology and implications for therapy. N Eng J Med 1990, 322(18):1277-1289.